Platelets become locally activated through the interaction of podoplanin with C-type lectin-like immune receptor 2 (CLEC-2) on tumor cells, as well as high-mobility group box 1 (HMGB1) with TLR4 [70,71]. The gene discussed is CLEC1B; the disease is neoplasm.